CDMO News
Cytovance Partners with Celltheon to Boost Biologics Manufacturing
Cytovance Biologics and Celltheon have announced a partnership to meet the growing demand for complex biologics development and manufacturing in the US. This collaboration integrates Celltheon’s CHO-K1-based cell line development platform with Cytovance’s CDMO services. Axel Schleyer, CCO of Cytovance,
31 July 2024
Stay ahead of trends and best practices
